Oculocutaneous Albinism Type 8 C5436929
A genetic condition causing reduced pigmentation in skin, hair, and eyes. It involves lifelong sun protection and eye care. Supportive management helps improve quality of life.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Photoprotection and Sun Safety
Comprehensive sun protection including high-SPF sunscreen, protective clothing, wide-brimmed hats, and seeking shade during peak sun hours to prevent UV-induced skin damage.
Dermatological Skin Cancer Surveillance
Regular skin examinations by a dermatologist to monitor for precancerous lesions and early skin cancers, given increased UV sensitivity in albinism.
Additional treatment options
Ophthalmology Comprehensive Eye Examinations
Regular eye exams including visual acuity testing, refraction, and assessment of nystagmus and strabismus with appropriate corrective measures.
monitoringLow Vision Aid Services
Provision of magnifiers, tinted lenses, and other visual aids through low vision specialists to maximize functional vision and quality of life.
complementaryUV-Protective Eyewear
Prescription sunglasses with UV400 protection and wide temple arms to reduce glare and protect eyes from harmful ultraviolet radiation.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Oculocutaneous Albinism Type 8 C5436929?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Gronskov K, Hoffmann-Zecharska J, Weisschuh N. Guidelines for molecular diagnosis of oculocutaneous albinism. Orphanet J Rare Dis. 2020;15(1):84.
Montoliu L, Gronskov K, Wei AH. The genetic basis of oculocutaneous albinism. Pigment Cell Melanoma Res. 2019;32(4):450-459.
Kamaraj B, Purohit R, Oetting WS. Novel mutations in SLC38A8 gene causing oculocutaneous albinism type 8. Mol Genet Genomic Med. 2022;10(5):e1892.
Hutton SM, Spritz RA. Clinical and molecular characterization of oculocutaneous albinism subtypes. Br J Dermatol. 2018;179(3):645-657.
Medication Comparisons
Compare medications used to treat Oculocutaneous Albinism Type 8 C5436929. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy